✦ LIBER ✦

Treatment of Low-Risk Myelodysplastic Syndrome: Hematopoietic Growth Factors Erythropoietins and Thrombopoietins

✍ Scribed by Valeria Santini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of anemia in low risk myelodys

✍ Economopoulos, T; Mellou, S; Papageorgiou, E; Pappa, V; Kokkinou, V; Stathopoulo 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 65 KB

Supportive Care and Use of Hematopoietic

✍ Eva Hellström-Lindberg; Luca Malcovati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Efficacy of growth factors compared to o

✍ Ali-Reza Golshayan; Tao Jin; Jaroslaw Maciejewski; Alex Z. Fu; Boris Bershadsky; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Involvement of transforming growth facto

✍ Akiyama, T; Matsunaga, T; Terui, T; Miyanishi, K; Tanaka, I; Sato, T; Kuroda, H; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 324 KB

Impact of growth factors in the regulati

✍ R. Tehranchi 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 248 KB

150 Treatment of low-risk MDS: Combinati

✍ D. Hoelzer; W.-K. Hofmann; G. Seipelt; A. Ganser 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 127 KB